GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Arntl
|
ENSMUSG00000055116.7 | aryl hydrocarbon receptor nuclear translocator-like |
Tfe3
|
ENSMUSG00000000134.11 | transcription factor E3 |
Mlx
|
ENSMUSG00000017801.9 | MAX-like protein X |
Mitf
|
ENSMUSG00000035158.9 | melanogenesis associated transcription factor |
Mlxipl
|
ENSMUSG00000005373.7 | MLX interacting protein-like |
Tfec
|
ENSMUSG00000029553.7 | transcription factor EC |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tfec | mm10_v2_chr6_-_16898441_16898459 | -0.84 | 2.2e-10 | Click! |
Mlxipl | mm10_v2_chr5_+_135106881_135106918 | 0.75 | 1.5e-07 | Click! |
Arntl | mm10_v2_chr7_+_113207465_113207595 | 0.46 | 4.4e-03 | Click! |
Mlx | mm10_v2_chr11_+_101087277_101087323 | 0.45 | 5.3e-03 | Click! |
Tfe3 | mm10_v2_chrX_+_7762652_7762695 | -0.43 | 9.1e-03 | Click! |
Mitf | mm10_v2_chr6_+_97807014_97807067 | 0.26 | 1.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_13159135 | 25.04 |
ENSMUST00000033824.6
|
Lamp1
|
lysosomal-associated membrane protein 1 |
chr1_+_130826676 | 20.46 |
ENSMUST00000027675.7
|
Pigr
|
polymeric immunoglobulin receptor |
chr1_+_130826762 | 18.79 |
ENSMUST00000133792.1
|
Pigr
|
polymeric immunoglobulin receptor |
chr7_-_97417730 | 16.69 |
ENSMUST00000043077.7
|
Thrsp
|
thyroid hormone responsive |
chr10_+_127063527 | 13.55 |
ENSMUST00000006911.5
|
Cdk4
|
cyclin-dependent kinase 4 |
chr3_+_90052814 | 13.18 |
ENSMUST00000160640.1
ENSMUST00000029552.6 ENSMUST00000162114.1 ENSMUST00000068798.6 |
4933434E20Rik
|
RIKEN cDNA 4933434E20 gene |
chr9_-_50561261 | 12.92 |
ENSMUST00000034568.5
|
Tex12
|
testis expressed gene 12 |
chr17_-_26939464 | 12.16 |
ENSMUST00000025027.8
ENSMUST00000114935.1 |
Cuta
|
cutA divalent cation tolerance homolog (E. coli) |
chr11_-_116199040 | 11.76 |
ENSMUST00000066587.5
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr1_+_166254095 | 11.20 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr3_+_67582737 | 9.90 |
ENSMUST00000029344.8
|
Mfsd1
|
major facilitator superfamily domain containing 1 |
chr12_-_84450944 | 9.69 |
ENSMUST00000085192.5
|
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr2_-_25356319 | 9.23 |
ENSMUST00000028332.7
|
Dpp7
|
dipeptidylpeptidase 7 |
chr11_-_116198701 | 9.10 |
ENSMUST00000072948.4
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr9_-_22002599 | 9.08 |
ENSMUST00000115336.2
ENSMUST00000044926.5 |
Ccdc151
|
coiled-coil domain containing 151 |
chr10_-_128923948 | 8.88 |
ENSMUST00000131271.1
|
Bloc1s1
|
biogenesis of lysosome-related organelles complex-1, subunit 1 |
chr15_-_3995708 | 8.60 |
ENSMUST00000046633.8
|
AW549877
|
expressed sequence AW549877 |
chr4_-_148038769 | 8.58 |
ENSMUST00000030879.5
ENSMUST00000137724.1 |
Clcn6
|
chloride channel 6 |
chr10_+_41519493 | 8.53 |
ENSMUST00000019962.8
|
Cd164
|
CD164 antigen |
chr2_+_102706356 | 8.45 |
ENSMUST00000123759.1
ENSMUST00000111212.1 ENSMUST00000005220.4 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr10_-_128922888 | 8.41 |
ENSMUST00000135161.1
|
Rdh5
|
retinol dehydrogenase 5 |
chr10_-_128923439 | 8.16 |
ENSMUST00000153731.1
ENSMUST00000026405.3 |
Bloc1s1
|
biogenesis of lysosome-related organelles complex-1, subunit 1 |
chr7_+_27195781 | 7.92 |
ENSMUST00000108379.1
ENSMUST00000179391.1 |
BC024978
|
cDNA sequence BC024978 |
chr15_+_10215955 | 7.76 |
ENSMUST00000130720.1
|
Prlr
|
prolactin receptor |
chr2_-_130424242 | 7.71 |
ENSMUST00000089581.4
|
Pced1a
|
PC-esterase domain containing 1A |
chr7_-_46742979 | 7.70 |
ENSMUST00000128088.1
|
Saa1
|
serum amyloid A 1 |
chr17_-_34743849 | 7.52 |
ENSMUST00000069507.8
|
C4b
|
complement component 4B (Chido blood group) |
chr2_+_122234749 | 7.40 |
ENSMUST00000110551.3
|
Sord
|
sorbitol dehydrogenase |
chr9_-_57683644 | 7.36 |
ENSMUST00000034860.3
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr9_+_55326913 | 7.28 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chr8_+_3500451 | 6.98 |
ENSMUST00000004683.6
ENSMUST00000160338.1 |
Mcoln1
|
mucolipin 1 |
chr4_+_129335593 | 6.97 |
ENSMUST00000141235.1
|
Zbtb8os
|
zinc finger and BTB domain containing 8 opposite strand |
chr8_-_84846860 | 6.86 |
ENSMUST00000003912.6
|
Calr
|
calreticulin |
chr9_+_46012810 | 6.86 |
ENSMUST00000126865.1
|
Sik3
|
SIK family kinase 3 |
chr10_+_121365078 | 6.84 |
ENSMUST00000040344.6
|
Gns
|
glucosamine (N-acetyl)-6-sulfatase |
chr16_+_45158725 | 6.59 |
ENSMUST00000023343.3
|
Atg3
|
autophagy related 3 |
chr4_-_117887292 | 6.58 |
ENSMUST00000150204.1
ENSMUST00000147845.1 ENSMUST00000036380.7 ENSMUST00000136596.1 |
Atp6v0b
|
ATPase, H+ transporting, lysosomal V0 subunit B |
chr5_+_30921825 | 6.54 |
ENSMUST00000117435.1
|
Khk
|
ketohexokinase |
chr16_-_5203981 | 6.51 |
ENSMUST00000147567.1
ENSMUST00000023911.4 |
Nagpa
|
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase |
chr4_+_129336012 | 6.47 |
ENSMUST00000119480.1
|
Zbtb8os
|
zinc finger and BTB domain containing 8 opposite strand |
chr10_-_4432312 | 6.38 |
ENSMUST00000126102.1
ENSMUST00000131853.1 ENSMUST00000042251.4 |
Rmnd1
|
required for meiotic nuclear division 1 homolog (S. cerevisiae) |
chr4_-_117887279 | 6.33 |
ENSMUST00000132073.1
|
Atp6v0b
|
ATPase, H+ transporting, lysosomal V0 subunit B |
chr17_-_56609689 | 6.23 |
ENSMUST00000052832.5
|
2410015M20Rik
|
RIKEN cDNA 2410015M20 gene |
chr11_-_113710017 | 6.21 |
ENSMUST00000018871.1
|
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr2_+_164833781 | 6.21 |
ENSMUST00000143780.1
|
Ctsa
|
cathepsin A |
chr17_+_24850484 | 6.16 |
ENSMUST00000118788.1
|
Hagh
|
hydroxyacyl glutathione hydrolase |
chr11_+_98348404 | 6.07 |
ENSMUST00000078694.6
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr10_-_39960144 | 6.05 |
ENSMUST00000095749.4
|
G630090E17Rik
|
RIKEN cDNA G630090E17 gene |
chr7_+_46796088 | 6.02 |
ENSMUST00000006774.4
ENSMUST00000165031.1 |
Gtf2h1
|
general transcription factor II H, polypeptide 1 |
chr7_-_126583177 | 5.98 |
ENSMUST00000098036.2
ENSMUST00000032962.4 |
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr7_+_101905837 | 5.89 |
ENSMUST00000033131.6
|
Lamtor1
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 |
chr8_-_106136792 | 5.88 |
ENSMUST00000146940.1
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chrX_+_103356464 | 5.82 |
ENSMUST00000116547.2
|
Chic1
|
cysteine-rich hydrophobic domain 1 |
chr3_-_89773221 | 5.81 |
ENSMUST00000038450.1
|
4632404H12Rik
|
RIKEN cDNA 4632404H12 gene |
chr2_+_164833841 | 5.79 |
ENSMUST00000152721.1
|
Ctsa
|
cathepsin A |
chr5_-_34187670 | 5.75 |
ENSMUST00000042701.6
ENSMUST00000119171.1 |
Mxd4
|
Max dimerization protein 4 |
chr7_-_99695572 | 5.75 |
ENSMUST00000137914.1
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr8_-_106136890 | 5.69 |
ENSMUST00000115979.2
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chr9_+_74953053 | 5.64 |
ENSMUST00000170846.1
|
Fam214a
|
family with sequence similarity 214, member A |
chr8_-_111630325 | 5.61 |
ENSMUST00000070004.3
|
Ldhd
|
lactate dehydrogenase D |
chr10_-_4432285 | 5.57 |
ENSMUST00000155172.1
|
Rmnd1
|
required for meiotic nuclear division 1 homolog (S. cerevisiae) |
chr3_+_130617448 | 5.54 |
ENSMUST00000166187.1
ENSMUST00000072271.6 |
Etnppl
|
ethanolamine phosphate phospholyase |
chr4_+_104766334 | 5.45 |
ENSMUST00000065072.6
|
C8b
|
complement component 8, beta polypeptide |
chr2_-_30286312 | 5.39 |
ENSMUST00000100219.3
|
Dolk
|
dolichol kinase |
chr1_+_75142775 | 5.38 |
ENSMUST00000097694.4
|
Fam134a
|
family with sequence similarity 134, member A |
chr16_-_45158650 | 5.37 |
ENSMUST00000023344.3
|
Slc35a5
|
solute carrier family 35, member A5 |
chr1_+_74713551 | 5.28 |
ENSMUST00000027356.5
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1 |
chr2_-_130424673 | 5.25 |
ENSMUST00000110277.1
|
Pced1a
|
PC-esterase domain containing 1A |
chr9_-_87255536 | 5.19 |
ENSMUST00000093802.4
|
4922501C03Rik
|
RIKEN cDNA 4922501C03 gene |
chr15_+_102921103 | 5.16 |
ENSMUST00000001700.6
|
Hoxc13
|
homeobox C13 |
chr7_-_46795881 | 5.07 |
ENSMUST00000107653.1
ENSMUST00000107654.1 ENSMUST00000014562.7 ENSMUST00000152759.1 |
Hps5
|
Hermansky-Pudlak syndrome 5 homolog (human) |
chr11_+_69991061 | 5.06 |
ENSMUST00000018711.8
|
Gabarap
|
gamma-aminobutyric acid receptor associated protein |
chr14_+_69171576 | 5.05 |
ENSMUST00000062437.8
|
Nkx2-6
|
NK2 homeobox 6 |
chr2_+_121449362 | 5.03 |
ENSMUST00000110615.1
ENSMUST00000099475.5 |
Serf2
|
small EDRK-rich factor 2 |
chr1_+_5083105 | 5.03 |
ENSMUST00000044369.7
|
Atp6v1h
|
ATPase, H+ transporting, lysosomal V1 subunit H |
chr7_-_99695628 | 4.94 |
ENSMUST00000145381.1
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr10_-_95416850 | 4.92 |
ENSMUST00000020215.9
|
Socs2
|
suppressor of cytokine signaling 2 |
chr17_+_45563928 | 4.92 |
ENSMUST00000041353.6
|
Slc35b2
|
solute carrier family 35, member B2 |
chr4_-_129239165 | 4.86 |
ENSMUST00000097873.3
|
C77080
|
expressed sequence C77080 |
chr9_+_46012822 | 4.82 |
ENSMUST00000120463.2
ENSMUST00000120247.1 |
Sik3
|
SIK family kinase 3 |
chr5_+_24428208 | 4.80 |
ENSMUST00000115049.2
|
Slc4a2
|
solute carrier family 4 (anion exchanger), member 2 |
chr16_+_20672716 | 4.77 |
ENSMUST00000044783.7
ENSMUST00000115463.1 ENSMUST00000142344.1 ENSMUST00000073840.5 ENSMUST00000140576.1 ENSMUST00000115457.1 |
Eif4g1
|
eukaryotic translation initiation factor 4, gamma 1 |
chr15_+_10714836 | 4.74 |
ENSMUST00000180604.1
|
4930556M19Rik
|
RIKEN cDNA 4930556M19 gene |
chr13_-_92131494 | 4.73 |
ENSMUST00000099326.3
ENSMUST00000146492.1 |
Rasgrf2
|
RAS protein-specific guanine nucleotide-releasing factor 2 |
chr11_+_120673018 | 4.64 |
ENSMUST00000106158.2
ENSMUST00000103016.1 ENSMUST00000168714.1 |
Aspscr1
|
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
chr6_-_72235559 | 4.64 |
ENSMUST00000042646.7
|
Atoh8
|
atonal homolog 8 (Drosophila) |
chr5_-_139814025 | 4.63 |
ENSMUST00000146780.1
|
Tmem184a
|
transmembrane protein 184a |
chr10_-_62486772 | 4.58 |
ENSMUST00000105447.3
|
Vps26a
|
vacuolar protein sorting 26 homolog A (yeast) |
chr7_-_99695809 | 4.52 |
ENSMUST00000107086.2
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr6_-_85869128 | 4.50 |
ENSMUST00000045008.7
|
Cml2
|
camello-like 2 |
chr3_+_130617645 | 4.48 |
ENSMUST00000163620.1
|
Etnppl
|
ethanolamine phosphate phospholyase |
chr11_-_60352869 | 4.47 |
ENSMUST00000095254.5
ENSMUST00000102683.4 ENSMUST00000093048.6 ENSMUST00000093046.6 ENSMUST00000064019.8 ENSMUST00000102682.4 |
Tom1l2
|
target of myb1-like 2 (chicken) |
chr4_+_104766308 | 4.45 |
ENSMUST00000031663.3
|
C8b
|
complement component 8, beta polypeptide |
chr8_+_104591464 | 4.45 |
ENSMUST00000059588.6
|
Pdp2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
chr10_-_62486575 | 4.45 |
ENSMUST00000092473.3
|
Vps26a
|
vacuolar protein sorting 26 homolog A (yeast) |
chr7_-_126377401 | 4.43 |
ENSMUST00000119846.1
ENSMUST00000119754.1 ENSMUST00000032994.8 |
Spns1
|
spinster homolog 1 |
chr8_-_93229517 | 4.42 |
ENSMUST00000176282.1
ENSMUST00000034173.7 |
Ces1e
|
carboxylesterase 1E |
chr10_-_95417099 | 4.42 |
ENSMUST00000135822.1
|
Socs2
|
suppressor of cytokine signaling 2 |
chr11_+_120672992 | 4.41 |
ENSMUST00000026135.8
|
Aspscr1
|
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
chr16_+_5233615 | 4.36 |
ENSMUST00000100196.2
ENSMUST00000049207.8 |
Alg1
|
asparagine-linked glycosylation 1 (beta-1,4-mannosyltransferase) |
chr7_+_46751832 | 4.35 |
ENSMUST00000075982.2
|
Saa2
|
serum amyloid A 2 |
chr11_-_98775333 | 4.34 |
ENSMUST00000064941.6
|
Nr1d1
|
nuclear receptor subfamily 1, group D, member 1 |
chr6_-_85707858 | 4.29 |
ENSMUST00000179613.1
|
Gm4477
|
predicted gene 4477 |
chr17_+_24850515 | 4.29 |
ENSMUST00000154363.1
ENSMUST00000169200.1 |
Hagh
|
hydroxyacyl glutathione hydrolase |
chr3_-_95882031 | 4.28 |
ENSMUST00000161994.1
|
Gm129
|
predicted gene 129 |
chr5_-_31154152 | 4.26 |
ENSMUST00000114632.1
ENSMUST00000114631.2 ENSMUST00000067186.6 ENSMUST00000137165.1 ENSMUST00000131391.1 ENSMUST00000141823.1 ENSMUST00000154241.1 |
Mpv17
|
MpV17 mitochondrial inner membrane protein |
chr1_+_88211956 | 4.24 |
ENSMUST00000073049.6
|
Ugt1a1
|
UDP glucuronosyltransferase 1 family, polypeptide A1 |
chr15_-_10714612 | 4.23 |
ENSMUST00000169385.1
|
Rai14
|
retinoic acid induced 14 |
chr5_+_30921556 | 4.23 |
ENSMUST00000031053.8
|
Khk
|
ketohexokinase |
chr1_+_135818593 | 4.19 |
ENSMUST00000038760.8
|
Lad1
|
ladinin |
chr14_-_118052235 | 4.19 |
ENSMUST00000022725.2
|
Dct
|
dopachrome tautomerase |
chr11_-_70239794 | 4.19 |
ENSMUST00000040428.3
|
Rnasek
|
ribonuclease, RNase K |
chr7_-_90475971 | 4.17 |
ENSMUST00000032843.7
|
Tmem126b
|
transmembrane protein 126B |
chr16_-_23988852 | 4.17 |
ENSMUST00000023151.5
|
Bcl6
|
B cell leukemia/lymphoma 6 |
chr7_+_44384604 | 4.16 |
ENSMUST00000130707.1
ENSMUST00000130844.1 |
Syt3
|
synaptotagmin III |
chr7_+_44384803 | 4.09 |
ENSMUST00000120262.1
|
Syt3
|
synaptotagmin III |
chr2_-_164833438 | 4.09 |
ENSMUST00000042775.4
|
Neurl2
|
neuralized-like 2 (Drosophila) |
chr5_+_28165690 | 4.09 |
ENSMUST00000036177.7
|
En2
|
engrailed 2 |
chr10_+_77606571 | 4.04 |
ENSMUST00000099538.5
|
Sumo3
|
SMT3 suppressor of mif two 3 homolog 3 (yeast) |
chr15_-_76126538 | 4.03 |
ENSMUST00000054022.5
ENSMUST00000089654.3 |
BC024139
|
cDNA sequence BC024139 |
chr2_+_28641227 | 4.00 |
ENSMUST00000028155.5
ENSMUST00000113869.1 ENSMUST00000113867.2 |
Tsc1
|
tuberous sclerosis 1 |
chr1_-_183297008 | 3.96 |
ENSMUST00000057062.5
|
Brox
|
BRO1 domain and CAAX motif containing |
chr6_+_108660616 | 3.93 |
ENSMUST00000032194.4
|
Bhlhe40
|
basic helix-loop-helix family, member e40 |
chr11_-_52000432 | 3.92 |
ENSMUST00000020657.6
|
Ube2b
|
ubiquitin-conjugating enzyme E2B |
chr18_+_31759817 | 3.90 |
ENSMUST00000115808.2
|
Ammecr1l
|
AMME chromosomal region gene 1-like |
chr2_+_90847149 | 3.87 |
ENSMUST00000136872.1
|
Mtch2
|
mitochondrial carrier homolog 2 (C. elegans) |
chr2_+_127425155 | 3.87 |
ENSMUST00000062211.3
ENSMUST00000110373.1 |
Gpat2
|
glycerol-3-phosphate acyltransferase 2, mitochondrial |
chr16_-_5049882 | 3.85 |
ENSMUST00000023189.7
ENSMUST00000115844.1 |
Glyr1
|
glyoxylate reductase 1 homolog (Arabidopsis) |
chr3_+_89202916 | 3.80 |
ENSMUST00000077367.4
ENSMUST00000167998.1 |
Gba
|
glucosidase, beta, acid |
chr17_+_25133385 | 3.79 |
ENSMUST00000040729.2
|
Clcn7
|
chloride channel 7 |
chr11_+_73199445 | 3.76 |
ENSMUST00000006105.6
|
Shpk
|
sedoheptulokinase |
chr11_-_5915124 | 3.73 |
ENSMUST00000109823.2
ENSMUST00000109822.1 |
Gck
|
glucokinase |
chr1_+_171345684 | 3.72 |
ENSMUST00000006579.4
|
Pfdn2
|
prefoldin 2 |
chr2_+_90847207 | 3.69 |
ENSMUST00000150232.1
ENSMUST00000111467.3 |
Mtch2
|
mitochondrial carrier homolog 2 (C. elegans) |
chr11_+_120673359 | 3.68 |
ENSMUST00000135346.1
ENSMUST00000127269.1 ENSMUST00000131727.2 ENSMUST00000149389.1 ENSMUST00000153346.1 |
Aspscr1
|
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
chr5_+_107331157 | 3.68 |
ENSMUST00000031215.8
ENSMUST00000112677.3 |
Brdt
|
bromodomain, testis-specific |
chr16_-_45158566 | 3.66 |
ENSMUST00000181177.1
|
Slc35a5
|
solute carrier family 35, member A5 |
chr6_-_108185552 | 3.62 |
ENSMUST00000167338.1
ENSMUST00000172188.1 ENSMUST00000032191.9 |
Sumf1
|
sulfatase modifying factor 1 |
chr5_+_30921867 | 3.61 |
ENSMUST00000123885.1
|
Khk
|
ketohexokinase |
chr9_+_77917364 | 3.60 |
ENSMUST00000034904.7
|
Elovl5
|
ELOVL family member 5, elongation of long chain fatty acids (yeast) |
chr1_-_139560158 | 3.59 |
ENSMUST00000160423.1
ENSMUST00000023965.5 |
Cfhr1
|
complement factor H-related 1 |
chr14_+_34819811 | 3.56 |
ENSMUST00000043349.5
|
Grid1
|
glutamate receptor, ionotropic, delta 1 |
chr18_-_6135888 | 3.54 |
ENSMUST00000182383.1
ENSMUST00000062584.7 ENSMUST00000077128.6 ENSMUST00000182038.1 ENSMUST00000182213.1 |
Arhgap12
|
Rho GTPase activating protein 12 |
chr11_-_96075581 | 3.51 |
ENSMUST00000107686.1
ENSMUST00000107684.1 |
Atp5g1
|
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c1 (subunit 9) |
chr17_+_46383725 | 3.50 |
ENSMUST00000113481.1
ENSMUST00000138127.1 |
Zfp318
|
zinc finger protein 318 |
chr16_-_44139196 | 3.45 |
ENSMUST00000063661.6
ENSMUST00000114666.2 |
Atp6v1a
|
ATPase, H+ transporting, lysosomal V1 subunit A |
chr5_-_139814231 | 3.43 |
ENSMUST00000044002.4
|
Tmem184a
|
transmembrane protein 184a |
chr7_+_119526269 | 3.42 |
ENSMUST00000066465.1
|
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr11_-_72266596 | 3.42 |
ENSMUST00000021161.6
ENSMUST00000140167.1 |
Slc13a5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5 |
chr17_-_32917048 | 3.37 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr7_+_121707189 | 3.36 |
ENSMUST00000065310.2
|
1700069B07Rik
|
RIKEN cDNA 1700069B07 gene |
chr4_-_119422355 | 3.35 |
ENSMUST00000106316.1
ENSMUST00000030385.6 |
Ppcs
|
phosphopantothenoylcysteine synthetase |
chr8_-_24576297 | 3.35 |
ENSMUST00000033953.7
ENSMUST00000121992.1 |
Ido2
|
indoleamine 2,3-dioxygenase 2 |
chr10_+_128322443 | 3.35 |
ENSMUST00000026446.2
|
Cnpy2
|
canopy 2 homolog (zebrafish) |
chr11_-_88863717 | 3.33 |
ENSMUST00000107904.2
|
Akap1
|
A kinase (PRKA) anchor protein 1 |
chr17_-_26508463 | 3.33 |
ENSMUST00000025025.6
|
Dusp1
|
dual specificity phosphatase 1 |
chr7_-_35802968 | 3.31 |
ENSMUST00000061586.4
|
Zfp507
|
zinc finger protein 507 |
chr7_-_126583523 | 3.31 |
ENSMUST00000125508.1
ENSMUST00000147086.1 ENSMUST00000150587.1 |
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr11_+_60777525 | 3.30 |
ENSMUST00000056907.6
ENSMUST00000102667.3 |
Smcr8
|
Smith-Magenis syndrome chromosome region, candidate 8 homolog (human) |
chr10_-_41587753 | 3.28 |
ENSMUST00000160751.1
|
Ccdc162
|
coiled-coil domain containing 162 |
chr9_-_48605147 | 3.27 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
Nnmt
|
nicotinamide N-methyltransferase |
chr11_+_94653767 | 3.24 |
ENSMUST00000025278.7
|
Mrpl27
|
mitochondrial ribosomal protein L27 |
chr11_-_60811228 | 3.20 |
ENSMUST00000018744.8
|
Shmt1
|
serine hydroxymethyltransferase 1 (soluble) |
chr11_-_86993682 | 3.20 |
ENSMUST00000018571.4
|
Ypel2
|
yippee-like 2 (Drosophila) |
chr10_-_81060134 | 3.19 |
ENSMUST00000005067.5
|
Sgta
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
chr4_-_96664112 | 3.17 |
ENSMUST00000030299.7
|
Cyp2j5
|
cytochrome P450, family 2, subfamily j, polypeptide 5 |
chr3_-_129332713 | 3.16 |
ENSMUST00000029658.7
|
Enpep
|
glutamyl aminopeptidase |
chr1_+_171225054 | 3.16 |
ENSMUST00000111321.1
ENSMUST00000005824.5 ENSMUST00000111320.1 ENSMUST00000111319.1 |
Apoa2
|
apolipoprotein A-II |
chr8_+_75033673 | 3.13 |
ENSMUST00000078847.5
ENSMUST00000165630.1 |
Tom1
|
target of myb1 homolog (chicken) |
chr1_-_162984519 | 3.13 |
ENSMUST00000028010.7
|
Fmo3
|
flavin containing monooxygenase 3 |
chr7_-_27166413 | 3.12 |
ENSMUST00000108382.1
|
Egln2
|
EGL nine homolog 2 (C. elegans) |
chr5_+_138171997 | 3.11 |
ENSMUST00000019662.4
ENSMUST00000151318.1 |
Ap4m1
|
adaptor-related protein complex AP-4, mu 1 |
chr17_+_33824591 | 3.09 |
ENSMUST00000048249.6
|
Ndufa7
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (B14.5a) |
chr6_-_39377681 | 3.07 |
ENSMUST00000090243.4
|
Slc37a3
|
solute carrier family 37 (glycerol-3-phosphate transporter), member 3 |
chr1_-_136960427 | 3.05 |
ENSMUST00000027649.7
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr11_-_96075655 | 3.04 |
ENSMUST00000090541.5
|
Atp5g1
|
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c1 (subunit 9) |
chr6_+_116208030 | 3.01 |
ENSMUST00000036759.8
|
Fam21
|
family with sequence similarity 21 |
chr6_+_17694167 | 3.01 |
ENSMUST00000115418.1
|
St7
|
suppression of tumorigenicity 7 |
chrX_-_100412587 | 2.98 |
ENSMUST00000033567.8
|
Awat2
|
acyl-CoA wax alcohol acyltransferase 2 |
chr4_-_70534904 | 2.98 |
ENSMUST00000107359.2
|
Megf9
|
multiple EGF-like-domains 9 |
chr19_+_39007019 | 2.97 |
ENSMUST00000025966.4
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr11_+_53350783 | 2.96 |
ENSMUST00000060945.5
|
Aff4
|
AF4/FMR2 family, member 4 |
chr16_-_45158624 | 2.92 |
ENSMUST00000180636.1
|
Slc35a5
|
solute carrier family 35, member A5 |
chr18_-_80151467 | 2.92 |
ENSMUST00000066743.9
|
Adnp2
|
ADNP homeobox 2 |
chr8_-_13890233 | 2.91 |
ENSMUST00000033839.7
|
Coprs
|
coordinator of PRMT5, differentiation stimulator |
chr19_-_58860975 | 2.91 |
ENSMUST00000066285.4
|
Hspa12a
|
heat shock protein 12A |
chr19_-_44407703 | 2.90 |
ENSMUST00000041331.2
|
Scd1
|
stearoyl-Coenzyme A desaturase 1 |
chr10_+_23894688 | 2.89 |
ENSMUST00000041416.7
|
Vnn1
|
vanin 1 |
chr5_+_138255608 | 2.87 |
ENSMUST00000062067.6
|
Lamtor4
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 |
chr19_-_39463067 | 2.87 |
ENSMUST00000035488.2
|
Cyp2c38
|
cytochrome P450, family 2, subfamily c, polypeptide 38 |
chr5_-_120503593 | 2.86 |
ENSMUST00000031597.6
|
Plbd2
|
phospholipase B domain containing 2 |
chr17_-_56074932 | 2.85 |
ENSMUST00000019722.5
|
Ubxn6
|
UBX domain protein 6 |
chr9_+_102626278 | 2.85 |
ENSMUST00000038673.7
|
Anapc13
|
anaphase promoting complex subunit 13 |
chr4_-_122961173 | 2.83 |
ENSMUST00000030408.5
ENSMUST00000127047.1 |
Mfsd2a
|
major facilitator superfamily domain containing 2A |
chr10_-_78464969 | 2.81 |
ENSMUST00000041616.8
|
Pdxk
|
pyridoxal (pyridoxine, vitamin B6) kinase |
chr12_-_103904887 | 2.81 |
ENSMUST00000074051.5
|
Serpina1c
|
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
chr5_-_86518578 | 2.76 |
ENSMUST00000134179.1
|
Tmprss11g
|
transmembrane protease, serine 11g |
chr12_+_86947343 | 2.75 |
ENSMUST00000038369.4
|
2310044G17Rik
|
RIKEN cDNA 2310044G17 gene |
chrX_-_85776606 | 2.74 |
ENSMUST00000142152.1
ENSMUST00000156390.1 ENSMUST00000113978.2 |
Gyk
|
glycerol kinase |
chr4_-_96553617 | 2.72 |
ENSMUST00000030303.5
|
Cyp2j6
|
cytochrome P450, family 2, subfamily j, polypeptide 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 40.4 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
8.5 | 25.5 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
3.8 | 15.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
3.8 | 15.2 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
3.8 | 11.4 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
3.6 | 14.4 | GO:0061624 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
3.5 | 20.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
2.5 | 15.3 | GO:0010288 | response to lead ion(GO:0010288) |
2.5 | 7.4 | GO:0019405 | alditol catabolic process(GO:0019405) |
2.5 | 7.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
2.1 | 6.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
2.0 | 12.0 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
1.9 | 11.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.9 | 9.3 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
1.7 | 5.2 | GO:1902617 | response to fluoride(GO:1902617) |
1.7 | 5.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
1.7 | 5.1 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
1.7 | 5.0 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
1.6 | 8.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.6 | 4.7 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
1.5 | 6.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.5 | 6.0 | GO:0015744 | succinate transport(GO:0015744) |
1.4 | 13.9 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.4 | 4.1 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
1.4 | 4.1 | GO:0060752 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
1.3 | 8.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.3 | 4.0 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
1.3 | 9.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
1.3 | 5.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
1.3 | 3.8 | GO:0043181 | vacuolar sequestering(GO:0043181) |
1.2 | 4.8 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
1.2 | 8.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.1 | 3.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.1 | 4.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.1 | 4.5 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
1.1 | 4.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.1 | 3.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.1 | 3.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.0 | 3.1 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
1.0 | 33.6 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
1.0 | 4.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.0 | 12.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
1.0 | 3.0 | GO:0070342 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
0.9 | 2.8 | GO:0051977 | lysophospholipid transport(GO:0051977) |
0.9 | 3.8 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.9 | 1.9 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.9 | 2.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.9 | 2.7 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.9 | 2.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.9 | 6.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.9 | 2.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.9 | 12.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.9 | 2.6 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.9 | 4.3 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.9 | 2.6 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.8 | 3.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 2.5 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.8 | 3.4 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.8 | 19.3 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.8 | 4.2 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.8 | 3.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.8 | 2.4 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.8 | 2.4 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.8 | 3.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.7 | 2.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 5.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.7 | 3.7 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.7 | 11.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 2.9 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.7 | 1.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.7 | 8.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.7 | 2.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.7 | 3.5 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.7 | 4.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.7 | 5.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 2.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.7 | 2.7 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.7 | 2.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.7 | 3.3 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.7 | 4.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.6 | 0.6 | GO:1904173 | regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
0.6 | 3.2 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.6 | 2.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.6 | 1.9 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.6 | 1.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.6 | 20.5 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.6 | 2.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.6 | 5.5 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.6 | 1.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.6 | 8.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.6 | 7.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.6 | 2.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.6 | 4.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.6 | 12.9 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.6 | 0.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.6 | 7.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.5 | 2.2 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.5 | 1.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.5 | 1.6 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.5 | 2.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 7.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.5 | 2.1 | GO:0071449 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
0.5 | 12.9 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 4.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.5 | 6.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 1.5 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.5 | 3.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.5 | 4.9 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 1.5 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.5 | 1.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.5 | 5.8 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 1.4 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.5 | 1.9 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.5 | 2.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 3.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 0.9 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.5 | 3.3 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.5 | 5.1 | GO:0035878 | nail development(GO:0035878) |
0.5 | 2.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 0.9 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.4 | 0.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.4 | 1.8 | GO:0061055 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) myotome development(GO:0061055) |
0.4 | 4.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 0.9 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.4 | 10.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.4 | 0.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 3.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 3.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 2.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.4 | 4.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 4.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.4 | 7.6 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.4 | 1.3 | GO:0032242 | regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.4 | 1.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 2.5 | GO:0015808 | L-alanine transport(GO:0015808) |
0.4 | 6.2 | GO:0042407 | cristae formation(GO:0042407) |
0.4 | 4.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.4 | 1.6 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.4 | 7.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.4 | 4.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.4 | 1.2 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.4 | 2.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.4 | 2.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 0.4 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.4 | 1.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 2.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 0.8 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.4 | 1.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) L-cystine transport(GO:0015811) |
0.4 | 1.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.4 | 1.1 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.4 | 9.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 1.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.4 | 0.4 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.4 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 1.9 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.4 | 1.1 | GO:0021893 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.4 | 0.7 | GO:0061026 | septum secundum development(GO:0003285) cardiac muscle tissue regeneration(GO:0061026) |
0.4 | 0.7 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.4 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 1.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.4 | 7.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 1.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 3.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 2.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 2.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 1.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 1.0 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.3 | 3.7 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.3 | 0.3 | GO:0002465 | peripheral T cell tolerance induction(GO:0002458) peripheral tolerance induction(GO:0002465) |
0.3 | 2.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 1.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 1.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.3 | GO:1903215 | regulation of mRNA modification(GO:0090365) negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 1.0 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.3 | 3.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 5.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.3 | 1.3 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.3 | 1.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.3 | 2.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.3 | 1.3 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.3 | 2.2 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 4.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 3.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 2.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 0.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.3 | 0.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.3 | 1.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.3 | 0.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.3 | 0.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 0.9 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) positive regulation of growth rate(GO:0040010) |
0.3 | 0.3 | GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) |
0.3 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.3 | 1.2 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.3 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.9 | GO:0002884 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
0.3 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
0.3 | 5.1 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.3 | 1.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.3 | 1.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 11.7 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.3 | 1.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.3 | 1.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 1.1 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.3 | 4.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 0.5 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.3 | 0.8 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 0.8 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.3 | 0.8 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.3 | 1.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 1.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.3 | 12.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 5.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 1.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 0.8 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.3 | 3.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 1.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 1.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.3 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 0.8 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.3 | 1.8 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.3 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 1.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 1.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.2 | 0.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.2 | 5.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.7 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 0.7 | GO:0003167 | atrioventricular bundle cell differentiation(GO:0003167) His-Purkinje system cell differentiation(GO:0060932) |
0.2 | 1.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 1.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.7 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.2 | 1.0 | GO:1902045 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.2 | 4.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 0.7 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.2 | 1.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 1.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.7 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 9.7 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 1.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.9 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 1.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.2 | 0.7 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 1.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 1.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 2.9 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 11.0 | GO:0006956 | complement activation(GO:0006956) |
0.2 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 2.7 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.2 | 0.7 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.2 | 0.4 | GO:1903817 | negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 1.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.2 | 0.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.2 | 3.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.9 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.4 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 2.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 0.9 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 1.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 1.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 1.0 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 1.8 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 2.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 4.7 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 3.4 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 5.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 1.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.4 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.2 | 0.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 0.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 1.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.4 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.2 | 1.8 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 11.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 1.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 0.6 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.2 | 0.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 3.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.6 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.2 | 1.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 4.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 1.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.9 | GO:1904720 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.2 | 33.3 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.2 | 1.3 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.2 | 0.7 | GO:0016259 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.2 | 2.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 1.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 3.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 1.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.2 | 0.5 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.9 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 1.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.5 | GO:0006203 | dGTP catabolic process(GO:0006203) dATP catabolic process(GO:0046061) |
0.2 | 1.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 1.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 1.3 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.2 | 1.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 3.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 2.0 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.2 | 1.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 3.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 6.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 1.6 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.2 | 0.5 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.2 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.2 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.2 | 0.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 1.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.9 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 1.9 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.8 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 2.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 0.8 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.2 | 0.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.7 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 1.5 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 1.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.6 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.4 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.1 | 0.3 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.1 | 5.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 1.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.6 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 0.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 1.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 2.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 2.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 2.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 1.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 1.7 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 2.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.9 | GO:0070627 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 1.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 1.5 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.4 | GO:0072343 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.1 | 0.5 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 1.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 4.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 1.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.8 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 1.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 1.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
0.1 | 11.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 4.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.4 | GO:1901950 | dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
0.1 | 2.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 1.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.3 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.1 | 3.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 1.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 3.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 1.0 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 1.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.1 | 0.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.2 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.1 | 1.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 1.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.4 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 1.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.4 | GO:0070071 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting two-sector ATPase complex assembly(GO:0070071) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 5.9 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 4.0 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.7 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 1.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.3 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.6 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 1.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 2.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.3 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.9 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 4.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 1.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 1.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 2.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.7 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 3.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 1.3 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.3 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) |
0.1 | 0.3 | GO:0007210 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
0.1 | 5.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 1.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.5 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 2.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 1.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.3 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.5 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 2.0 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 2.1 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 3.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.2 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.1 | 0.9 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.3 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.1 | 0.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 0.3 | GO:0052042 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.1 | 0.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 1.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.7 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.1 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 2.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 3.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 1.1 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 1.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 1.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 2.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0015881 | creatine transport(GO:0015881) |
0.1 | 0.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 1.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.7 | GO:0060180 | female mating behavior(GO:0060180) |
0.1 | 0.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.3 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.1 | 0.5 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.1 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 1.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 1.3 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 1.3 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 1.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.1 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.1 | 0.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.3 | GO:0009814 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) subthalamus development(GO:0021539) |
0.1 | 0.3 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.3 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 2.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 2.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 4.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.6 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.7 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 2.0 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 1.0 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 0.3 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.1 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.2 | GO:0051030 | snRNA transport(GO:0051030) |
0.1 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 1.4 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.7 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 2.9 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.0 | 0.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.5 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 0.5 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.6 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.1 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 1.0 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 1.7 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.2 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.0 | 1.0 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.3 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 1.1 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.4 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.4 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 1.0 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 1.5 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 2.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 1.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 3.1 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.4 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.7 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 0.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.5 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.8 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.0 | 0.1 | GO:2000292 | regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.5 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.7 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 0.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.0 | 0.1 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.0 | 0.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.5 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 1.1 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.1 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 1.0 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 1.2 | GO:0008306 | associative learning(GO:0008306) |
0.0 | 0.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 1.4 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.7 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
0.0 | 0.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.5 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 0.3 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.2 | GO:0044346 | fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.3 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.0 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.3 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.1 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.5 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.0 | 0.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 2.8 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.0 | 0.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.0 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.2 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.7 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.3 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.0 | 0.5 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.4 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.0 | 0.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.8 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.0 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 25.0 | GO:0032010 | phagolysosome(GO:0032010) |
3.8 | 15.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
2.3 | 9.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
1.8 | 14.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.4 | 5.8 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
1.4 | 1.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.4 | 4.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
1.3 | 13.0 | GO:0000801 | central element(GO:0000801) |
1.3 | 3.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.2 | 13.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.1 | 19.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
1.1 | 6.6 | GO:0071986 | Ragulator complex(GO:0071986) |
1.1 | 7.7 | GO:0033263 | CORVET complex(GO:0033263) |
1.0 | 1.0 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
1.0 | 11.2 | GO:0005579 | membrane attack complex(GO:0005579) |
1.0 | 4.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.9 | 3.6 | GO:0097447 | dendritic tree(GO:0097447) |
0.9 | 2.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.9 | 4.4 | GO:0030891 | VCB complex(GO:0030891) |
0.9 | 37.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.8 | 0.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.8 | 2.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.8 | 7.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.8 | 6.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.8 | 5.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.7 | 6.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.7 | 2.2 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.7 | 5.1 | GO:0033503 | HULC complex(GO:0033503) |
0.7 | 5.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 25.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 6.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.7 | 6.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.7 | 9.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 3.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 4.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.6 | 2.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.5 | 2.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 3.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.5 | 4.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 6.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.5 | 10.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 4.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.4 | 1.7 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.4 | 5.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 1.6 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.4 | 4.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 3.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 3.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 32.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 1.8 | GO:0042627 | chylomicron(GO:0042627) |
0.4 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 5.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 2.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.0 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.3 | 1.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 1.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 25.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 5.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 1.8 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.3 | 6.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 11.4 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 0.8 | GO:0036019 | endolysosome(GO:0036019) |
0.3 | 13.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 4.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 5.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.8 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.2 | 0.9 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.2 | 3.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 1.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 2.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 28.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 8.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 0.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 4.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 1.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 2.6 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 2.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 1.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 1.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.2 | 0.9 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 1.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 1.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 8.0 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 2.2 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 2.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 3.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 71.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 6.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 13.8 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.9 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.8 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 14.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 15.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 2.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 9.5 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 2.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 44.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 3.2 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 1.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 5.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
0.1 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 0.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 2.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.4 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.1 | 4.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 2.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 2.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 2.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 2.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.5 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 2.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 6.1 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 13.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.3 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 3.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.1 | GO:0005713 | recombination nodule(GO:0005713) |
0.0 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 1.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.9 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 50.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 9.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 1.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.8 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 4.5 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 1.4 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.6 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 2.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.8 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.4 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 0.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0043512 | inhibin A complex(GO:0043512) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 19.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 3.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 1.7 | GO:0012506 | vesicle membrane(GO:0012506) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.2 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 1.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.4 | GO:0004454 | ketohexokinase activity(GO:0004454) |
4.1 | 41.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
3.5 | 20.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
3.3 | 10.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
2.2 | 6.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
2.2 | 10.9 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
2.0 | 6.1 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
2.0 | 10.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.9 | 5.6 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
1.8 | 5.4 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.7 | 7.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.7 | 10.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.7 | 5.2 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
1.6 | 4.9 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
1.5 | 13.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.5 | 4.6 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.4 | 4.3 | GO:0031403 | lithium ion binding(GO:0031403) |
1.4 | 5.7 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
1.4 | 8.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.4 | 4.1 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
1.4 | 6.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.3 | 5.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.3 | 5.4 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
1.3 | 4.0 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.3 | 3.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.3 | 3.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
1.2 | 3.7 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
1.2 | 4.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
1.2 | 6.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.1 | 3.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.1 | 4.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.0 | 4.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.0 | 8.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.0 | 27.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.9 | 3.8 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.9 | 19.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.9 | 2.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.9 | 0.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.9 | 0.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.9 | 11.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.9 | 1.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.9 | 6.8 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.8 | 2.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.8 | 2.5 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
0.8 | 5.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.8 | 2.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 9.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.8 | 0.8 | GO:0019863 | IgE binding(GO:0019863) |
0.7 | 3.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.7 | 17.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.7 | 2.8 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.7 | 6.9 | GO:0043426 | MRF binding(GO:0043426) |
0.7 | 2.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.7 | 10.1 | GO:0031386 | protein tag(GO:0031386) |
0.7 | 2.0 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.6 | 3.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 11.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.6 | 1.9 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.6 | 4.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.6 | 5.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.6 | 0.6 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.6 | 2.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 10.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.6 | 9.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.6 | 3.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.6 | 5.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.5 | 2.7 | GO:0032810 | sterol response element binding(GO:0032810) |
0.5 | 4.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 3.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 3.4 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.5 | 1.5 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.5 | 5.8 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 1.4 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.5 | 1.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.5 | 3.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.5 | 1.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 5.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 2.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 6.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.4 | 1.3 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.4 | 1.3 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.4 | 1.3 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.4 | 2.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 1.2 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.4 | 1.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 4.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 7.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 1.6 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.4 | 19.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.4 | 3.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 5.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.4 | 1.6 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.4 | 1.5 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.4 | 1.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.4 | 1.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.4 | 1.5 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.4 | 2.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 1.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 1.1 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
0.4 | 1.8 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.4 | 1.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.4 | 1.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.4 | 1.4 | GO:0016822 | oxaloacetate decarboxylase activity(GO:0008948) hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 0.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.3 | 1.0 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.3 | 4.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 1.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 3.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.3 | 1.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 1.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 2.0 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.3 | 12.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 1.0 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.3 | 1.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 2.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 1.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 1.6 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.3 | 15.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 1.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 10.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 1.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.3 | 1.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 3.0 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 4.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 1.2 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.3 | 2.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 4.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 0.8 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.3 | 1.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 2.2 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 5.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.3 | 1.3 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) glycerol channel activity(GO:0015254) |
0.3 | 3.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.7 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.2 | 7.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 0.7 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.2 | 1.7 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 8.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 2.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 3.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.9 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 1.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.2 | GO:0004449 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.9 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 0.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.2 | 0.7 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.2 | 2.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 2.2 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 2.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 1.5 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.2 | 1.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 0.6 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.2 | 1.9 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.6 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.2 | 1.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 5.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 1.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 1.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 4.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 1.4 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 0.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 1.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 1.7 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 0.7 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.2 | 1.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 8.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 1.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 0.5 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.2 | 4.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.9 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 1.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.2 | 2.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 2.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.5 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.2 | 1.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 0.5 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.2 | 2.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 1.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 2.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 3.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.8 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 5.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.2 | 0.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 0.8 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.2 | 2.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.7 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.2 | 1.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.8 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.2 | 3.6 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 0.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 2.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 4.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 10.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 2.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 2.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 1.6 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.1 | 1.0 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 1.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 1.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.3 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 3.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 3.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 1.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 5.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 6.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 3.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 3.6 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 1.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.8 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 6.9 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 9.9 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.5 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 2.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 5.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 2.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 4.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 2.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 3.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 1.7 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 6.9 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 2.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 1.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 10.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.5 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.1 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 1.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.4 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.1 | 0.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 1.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 2.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0017099 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.2 | GO:0030060 | malate dehydrogenase activity(GO:0016615) L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.3 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.1 | 1.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 2.3 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.9 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.1 | 0.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 2.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 1.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 6.7 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.4 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.1 | 1.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 1.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.3 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 0.3 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.1 | 0.5 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 1.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.0 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 3.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 1.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 1.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 1.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 9.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.3 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 1.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 0.2 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.1 | 0.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 1.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 13.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.7 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 2.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 1.4 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.1 | 9.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 2.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.2 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 1.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 1.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 1.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.3 | GO:0032029 | myosin tail binding(GO:0032029) |
0.1 | 2.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.5 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 0.5 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 1.6 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 1.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 1.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 1.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 12.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 2.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 1.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 1.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 1.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.7 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.0 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 1.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 1.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.3 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 1.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.2 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 1.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 2.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.0 | 0.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 2.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) 7S RNA binding(GO:0008312) |
0.0 | 0.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 1.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.0 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.0 | 0.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.6 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.0 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0051381 | histamine binding(GO:0051381) |
0.0 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.2 | GO:0004629 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 14.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 47.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 1.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 6.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 4.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 14.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 20.0 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 4.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 10.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 6.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 9.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 8.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 5.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 5.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 5.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 4.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 1.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 5.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 5.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 4.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 2.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 12.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.7 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 2.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.0 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.3 | 29.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.1 | 12.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.1 | 14.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.0 | 9.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.9 | 32.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.9 | 9.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 13.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.6 | 23.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 5.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.6 | 9.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.6 | 16.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.5 | 18.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.5 | 6.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 6.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 14.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.4 | 6.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.4 | 6.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 5.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.4 | 6.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.4 | 4.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 6.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 5.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 4.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 5.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 4.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 3.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 5.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 2.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 2.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 7.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 5.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 8.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 3.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.3 | 2.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.7 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 4.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 4.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 5.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 6.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 3.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 11.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 5.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 2.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 11.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 1.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 1.4 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 14.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 4.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 1.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 8.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 1.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 2.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 3.6 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 1.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 2.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 4.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 2.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 5.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 4.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 4.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 2.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 6.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 10.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 1.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 3.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.5 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 1.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 1.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.8 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 1.1 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 1.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 2.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |